tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Maneka Mirchandaney, 8 are a BUY (66.67%), 4 are a HOLD (33.33%).
Analyst Maneka Mirchandaney, currently employed carries an average stock price target met ratio of 46.67% that have a potential upside of 28.92% achieved within 129 days.
Maneka Mirchandaney’s has documented 24 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 11-Sep-2023.
Analyst best performing recommendations are on SGEN (SEAGEN).
The best stock recommendation documented was for SGEN (SEAGEN) at 5/17/2021. The price target of $153 was fulfilled within 3 days with a profit of $5.02 (3.39%) receiving and performance score of 11.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$80
$19.31 (31.82%)
$80
1 months 17 days ago
(27-Sep-2024)
9/13 (69.23%)
$29.25 (57.64%)
394
Buy
$90
$29.31 (48.29%)
$65
1 months 28 days ago
(16-Sep-2024)
3/6 (50%)
$36.06 (66.85%)
131
Buy
$69
$8.31 (13.69%)
$60
3 months 4 days ago
(09-Aug-2024)
13/14 (92.86%)
$21.36 (44.84%)
322
Buy
$73
$12.31 (20.28%)
$74
3 months 4 days ago
(09-Aug-2024)
4/6 (66.67%)
$25.36 (53.23%)
130
Buy
$54
$-6.69 (-11.02%)
$35
4 months 4 days ago
(09-Jul-2024)
8/8 (100%)
$5.77 (11.96%)
203
What Year was the first public recommendation made by Maneka Mirchandaney?
